ConductScience.org, home

Paper23948467

Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.

Hausner M and 4 others. Microb Pathog, 2013. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan. Papers, record 23948467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23948467

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.
PubMed
Journal
Microb Pathog
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.07
iCite
Revised in PubMed
2013-10-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hausner MMarius
2Schamberger AAnna
3Naumann WWolfgang
4Jacobs EEnno
5Dumke RRoger

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adhesins, BacterialMajor topic
Adjuvants, ImmunologicMajor topic
Antibodies, BacterialMajor topic
Bacterial VaccinesMajor topic
ChitosanMajor topic
Mycoplasma pneumoniaeMajor topic
Administration, Intranasal
Animals
Bacterial Adhesion
Bacterial Load
Disease Models, Animal
Epithelial Cells
Guinea Pigs
HeLa Cells
Humans
Injections, Subcutaneous
Lung
Pneumonia, Mycoplasma
Recombinant Proteins
Vaccination
Vaccines, Synthetic

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42840255A multi-epitope vaccine targeting Mycoplasma pneumoniae P1 adhesin and CARDS toxin confers synergistic protection by adhesion inhibition and toxin neutralization.Front Immunol2026https://conductscience.org/library/papers/42840255PubMed
42042806Three-Component Subunit Vaccine Induces Protective Immunity Against Mycoplasma pneumoniae in Mice.Vaccines (Basel)2026https://conductscience.org/library/papers/42042806PubMed
41822501Immune dysregulation in Mycoplasma pneumoniae pneumonia: mechanistic controversies and clinical translation from inflammatory dysregulation and immune evasion to chronic injury.Front Immunol2026https://conductscience.org/library/papers/41822501PubMed
41438744Development of human mycoplasma vaccines: navigating the IL-17A paradox.Front Immunol2025https://conductscience.org/library/papers/41438744PubMed
41156647Therapeutic Efficacy of an Anti-P116-661 Polyclonal Antibody Against Mycoplasma pneumoniae Infection.Pathogens2025https://conductscience.org/library/papers/41156647PubMed
41012172Adjuvant Mucosal Strategies Confer Safe and Effective Immunity Against Mycoplasma pneumoniae and Overcome Vaccine-Associated Enhanced Lung Pathology.Vaccines (Basel)2025https://conductscience.org/library/papers/41012172PubMed
40771685Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection.Front Microbiol2025https://conductscience.org/library/papers/40771685PubMed
40469165Changes of serum inflammatory markers and immune function in children with bronchial asthma complicated with mycoplasma pneumoniae infection before and after treatment and their clinical significance.Pak J Med Sci2025https://conductscience.org/library/papers/40469165PubMed
39735188Reviewing advancement in Mycoplasma pneumoniae P30 adhesin protein provides insights for future diagnosis and treatment.Front Microbiol2024https://conductscience.org/library/papers/39735188PubMed
39291404Research of recombinant influenza A virus as a vector for Mycoplasma pneumoniae P1a and P30a.Immun Inflamm Dis2024https://conductscience.org/library/papers/39291404PubMed
38765654Exploring the pathogenetic mechanisms of Mycoplasmapneumoniae (Review).Exp Ther Med2024https://conductscience.org/library/papers/38765654PubMed
35646746Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/35646746PubMed
33503845Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development.Pathogens2021https://conductscience.org/library/papers/33503845PubMed
32286369Cell surface processing of the P1 adhesin of Mycoplasma pneumoniae identifies novel domains that bind host molecules.Sci Rep2020https://conductscience.org/library/papers/32286369PubMed
31611272Toll-Like Receptor 2 (TLR2) and TLR4 Mediate the IgA Immune Response Induced by Mycoplasma hyopneumoniae.Infect Immun2019https://conductscience.org/library/papers/31611272PubMed
30396892Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.Infect Immun2019https://conductscience.org/library/papers/30396892PubMed
29749357Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.Indian J Med Res2018https://conductscience.org/library/papers/29749357PubMed
27667580Insights into the pathogenesis of Mycoplasma pneumoniae (Review).Mol Med Rep2016https://conductscience.org/library/papers/27667580PubMed
27537186Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in Mice.PLoS One2016https://conductscience.org/library/papers/27537186PubMed
27148202A Compendium for Mycoplasma pneumoniae.Front Microbiol2016https://conductscience.org/library/papers/27148202PubMed

See all 22 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CENPV201161PubTator's text mininghttps://conductscience.org/library/genes/201161

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23948467

GET https://conductscience.org/api/papers/v1/23948467/cited_by?page=2